A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements
Triple negative breast cancer (TNBC), representing 10-15% of breast tumors diagnosed each year, is a clinically defined subtype of breast cancer associated with poor prognosis. The higher incidence of TNBC in certain populations such as young women and/or women of African ancestry and a unique patho...
Main Authors: | Darrell L. Ellsworth, Clesson E. Turner, Rachel E. Ellsworth |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2019/4382606 |
Similar Items
-
Genetic testing in patients with triple negative or hereditary breast Cancer
by: J. Garber
Published: (2021-04-01) -
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors
by: Imke H. Bartelink, et al.
Published: (2017-09-01) -
Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
by: Seth K. Rummel, et al.
Published: (2020-01-01) -
TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01) -
Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)